Add to Favourites
To login click here
Researchers from the University of California have developed a novel AI platform, POLYGON, that uses generative AI and reinforcement learning to generate new drug compounds capable of inhibiting multiple molecular targets at once. This platform has the potential to streamline the drug discovery process and create polypharmacology drugs with potential advantages over traditional single-target therapies.
